TRIM28 variants and Wilms' tumour predisposition
TRIM28 was recently identified as a Wilms' tumour (WT) predisposition gene, with germline pathogenic variants identified in around 1% of isolated and 8% of familial WT cases. TRIM28 variants are associated with epithelial WT, but the presence of other tumour components or anaplasia does not exc...
Saved in:
Published in | The Journal of pathology Vol. 254; no. 4; pp. 494 - 504 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.07.2021
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0022-3417 1096-9896 1096-9896 |
DOI | 10.1002/path.5639 |
Cover
Abstract | TRIM28 was recently identified as a Wilms' tumour (WT) predisposition gene, with germline pathogenic variants identified in around 1% of isolated and 8% of familial WT cases. TRIM28 variants are associated with epithelial WT, but the presence of other tumour components or anaplasia does not exclude the presence of a germline or somatic TRIM28 variant. In children with WT, TRIM28 acts as a classical tumour suppressor gene, with both alleles generally disrupted in the tumour. Therefore, loss of TRIM28 (KAP1/TIF1beta) protein expression in tumour tissue by immunohistochemistry is an effective strategy to identify patients carrying pathogenic TRIM28 variants. TRIM28 is a ubiquitously expressed corepressor that binds transcription factors in a context‐, species‐, and cell‐type‐specific manner to control the expression of genes and transposable elements during embryogenesis and cellular differentiation. In this review, we describe the inheritance patterns, histopathological and clinical features of TRIM28‐associated WT, as well as potential underlying mechanisms of tumourigenesis during embryonic kidney development. Recognizing germline TRIM28 variants in patients with WT can enable counselling, genetic testing, and potential early detection of WT in other children in the family. A further exploration of TRIM28‐associated WT will help to unravel the diverse and complex mechanisms underlying WT development. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. |
---|---|
AbstractList | TRIM28
was recently identified as a Wilms' tumour (WT) predisposition gene, with germline pathogenic variants identified in around 1% of isolated and 8% of familial WT cases.
TRIM28
variants are associated with epithelial WT, but the presence of other tumour components or anaplasia does not exclude the presence of a germline or somatic
TRIM28
variant. In children with WT,
TRIM28
acts as a classical tumour suppressor gene, with both alleles generally disrupted in the tumour. Therefore, loss of TRIM28 (KAP1/TIF1beta) protein expression in tumour tissue by immunohistochemistry is an effective strategy to identify patients carrying pathogenic
TRIM28
variants. TRIM28 is a ubiquitously expressed corepressor that binds transcription factors in a context‐, species‐, and cell‐type‐specific manner to control the expression of genes and transposable elements during embryogenesis and cellular differentiation. In this review, we describe the inheritance patterns, histopathological and clinical features of
TRIM28‐
associated WT, as well as potential underlying mechanisms of tumourigenesis during embryonic kidney development. Recognizing germline
TRIM28
variants in patients with WT can enable counselling, genetic testing, and potential early detection of WT in other children in the family. A further exploration of
TRIM28‐
associated WT will help to unravel the diverse and complex mechanisms underlying WT development. © 2021 The Authors.
The Journal of Pathology
published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. TRIM28 was recently identified as a Wilms' tumour (WT) predisposition gene, with germline pathogenic variants identified in around 1% of isolated and 8% of familial WT cases. TRIM28 variants are associated with epithelial WT, but the presence of other tumour components or anaplasia does not exclude the presence of a germline or somatic TRIM28 variant. In children with WT, TRIM28 acts as a classical tumour suppressor gene, with both alleles generally disrupted in the tumour. Therefore, loss of TRIM28 (KAP1/TIF1beta) protein expression in tumour tissue by immunohistochemistry is an effective strategy to identify patients carrying pathogenic TRIM28 variants. TRIM28 is a ubiquitously expressed corepressor that binds transcription factors in a context‐, species‐, and cell‐type‐specific manner to control the expression of genes and transposable elements during embryogenesis and cellular differentiation. In this review, we describe the inheritance patterns, histopathological and clinical features of TRIM28‐associated WT, as well as potential underlying mechanisms of tumourigenesis during embryonic kidney development. Recognizing germline TRIM28 variants in patients with WT can enable counselling, genetic testing, and potential early detection of WT in other children in the family. A further exploration of TRIM28‐associated WT will help to unravel the diverse and complex mechanisms underlying WT development. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. TRIM28 was recently identified as a Wilms' tumour (WT) predisposition gene, with germline pathogenic variants identified in around 1% of isolated and 8% of familial WT cases. TRIM28 variants are associated with epithelial WT, but the presence of other tumour components or anaplasia does not exclude the presence of a germline or somatic TRIM28 variant. In children with WT, TRIM28 acts as a classical tumour suppressor gene, with both alleles generally disrupted in the tumour. Therefore, loss of TRIM28 (KAP1/TIF1beta) protein expression in tumour tissue by immunohistochemistry is an effective strategy to identify patients carrying pathogenic TRIM28 variants. TRIM28 is a ubiquitously expressed corepressor that binds transcription factors in a context-, species-, and cell-type-specific manner to control the expression of genes and transposable elements during embryogenesis and cellular differentiation. In this review, we describe the inheritance patterns, histopathological and clinical features of TRIM28-associated WT, as well as potential underlying mechanisms of tumourigenesis during embryonic kidney development. Recognizing germline TRIM28 variants in patients with WT can enable counselling, genetic testing, and potential early detection of WT in other children in the family. A further exploration of TRIM28-associated WT will help to unravel the diverse and complex mechanisms underlying WT development. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.TRIM28 was recently identified as a Wilms' tumour (WT) predisposition gene, with germline pathogenic variants identified in around 1% of isolated and 8% of familial WT cases. TRIM28 variants are associated with epithelial WT, but the presence of other tumour components or anaplasia does not exclude the presence of a germline or somatic TRIM28 variant. In children with WT, TRIM28 acts as a classical tumour suppressor gene, with both alleles generally disrupted in the tumour. Therefore, loss of TRIM28 (KAP1/TIF1beta) protein expression in tumour tissue by immunohistochemistry is an effective strategy to identify patients carrying pathogenic TRIM28 variants. TRIM28 is a ubiquitously expressed corepressor that binds transcription factors in a context-, species-, and cell-type-specific manner to control the expression of genes and transposable elements during embryogenesis and cellular differentiation. In this review, we describe the inheritance patterns, histopathological and clinical features of TRIM28-associated WT, as well as potential underlying mechanisms of tumourigenesis during embryonic kidney development. Recognizing germline TRIM28 variants in patients with WT can enable counselling, genetic testing, and potential early detection of WT in other children in the family. A further exploration of TRIM28-associated WT will help to unravel the diverse and complex mechanisms underlying WT development. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. |
Author | Krijger, Ronald R Heuvel‐Eibrink, Marry M Kuiper, Roland P Hol, Janna A Diets, Illja J Jongmans, Marjolijn CJ |
AuthorAffiliation | 1 Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands 3 Department of Pathology University Medical Center Utrecht Utrecht The Netherlands 4 Department of Genetics University Medical Center Utrecht/Wilhelmina Children's Hospital Utrecht The Netherlands 2 Department of Human Genetics Radboud University Medical Center Nijmegen The Netherlands |
AuthorAffiliation_xml | – name: 2 Department of Human Genetics Radboud University Medical Center Nijmegen The Netherlands – name: 1 Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands – name: 4 Department of Genetics University Medical Center Utrecht/Wilhelmina Children's Hospital Utrecht The Netherlands – name: 3 Department of Pathology University Medical Center Utrecht Utrecht The Netherlands |
Author_xml | – sequence: 1 givenname: Janna A orcidid: 0000-0002-3156-5229 surname: Hol fullname: Hol, Janna A organization: Princess Máxima Center for Pediatric Oncology – sequence: 2 givenname: Illja J surname: Diets fullname: Diets, Illja J organization: Radboud University Medical Center – sequence: 3 givenname: Ronald R surname: Krijger fullname: Krijger, Ronald R organization: University Medical Center Utrecht – sequence: 4 givenname: Marry M surname: Heuvel‐Eibrink fullname: Heuvel‐Eibrink, Marry M organization: Princess Máxima Center for Pediatric Oncology – sequence: 5 givenname: Marjolijn CJ surname: Jongmans fullname: Jongmans, Marjolijn CJ organization: University Medical Center Utrecht/Wilhelmina Children's Hospital – sequence: 6 givenname: Roland P orcidid: 0000-0003-4928-3809 surname: Kuiper fullname: Kuiper, Roland P email: r.kuiper@prinsesmaximacentrum.nl organization: University Medical Center Utrecht/Wilhelmina Children's Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33565090$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtLxDAUhYMozvhY-Aek4EJdVG-apG02wiC-YESREZch06YaaZOatIr_3tQXOqCb3MX97sk996yhZWONQmgLwwEGSA5b2T0csJTwJTTGwNOY5zxdRuPQS2JCcTZCa94_AgDnjK2iESEsZcBhjGB2c3GZ5NGzdFqazkfSlNGdrhu_G3V9Y3sXtU6V2rfW605bs4FWKll7tflZ19Ht6cns-DyeXp1dHE-mcUEp4XHBOS0VLnBaVWlOyRxXwGTJsKwqkIThMmNQUoVZhXlC8wyXnHGWqoJkOaWKrKOjD922nzeqLJTpnKxF63Qj3auwUovfHaMfxL19FnnCkpRAENj7FHD2qVe-E432hapraZTtvQif5jgDYAO6s4A-BuMm2BMJIxkbHhyo7Z8bfa_ydcwA7H8AhbPeO1V9IxjEEJQYghJDUIE9XGAL3cnhwMGMrv-beNG1ev1bWlxPZufvE29ouKM1 |
CitedBy_id | crossref_primary_10_2174_1381612829666230721122011 crossref_primary_10_3390_cancers14071607 crossref_primary_10_1038_s41431_024_01545_7 crossref_primary_10_1002_path_6206 crossref_primary_10_1038_s41467_022_32061_1 crossref_primary_10_1002_path_5687 crossref_primary_10_1038_s41572_021_00308_8 crossref_primary_10_3389_fimmu_2024_1279920 crossref_primary_10_3389_fgene_2024_1431564 crossref_primary_10_1038_s41467_023_43730_0 crossref_primary_10_3390_cancers13133142 crossref_primary_10_1158_1078_0432_CCR_24_2488 crossref_primary_10_1016_j_jbc_2023_104621 crossref_primary_10_3390_cancers14235967 crossref_primary_10_1002_pbc_29984 crossref_primary_10_3389_fonc_2023_1137346 |
Cites_doi | 10.1002/ajmg.c.30025 10.1016/j.ejca.2012.06.008 10.1371/journal.pgen.1007399 10.1186/s13073-015-0136-4 10.1200/JCO.2015.62.1888 10.1101/gad.256396.114 10.1002/(SICI)1096-8628(19981002)79:4<268::AID-AJMG7>3.0.CO;2-I 10.1101/gr.172833.114 10.1002/pbc.22496 10.1158/0008-5472.CAN-07-1478 10.1007/s00467-013-2671-9 10.1016/j.gene.2013.01.008 10.1038/s41581-019-0112-0 10.1002/mpo.1276 10.1073/pnas.1217692110 10.1038/nature08674 10.1101/gr.147678.112 10.1016/j.stemcr.2020.03.013 10.1126/science.aax1323 10.1242/dev.127.13.2955 10.1038/nrmicro2783 10.1016/j.ccell.2015.01.002 10.1101/mcs.a004796 10.1371/journal.pgen.0030089 10.1038/nrc.2017.35 10.1136/adc.2006.101295 10.1038/nsmb.2878 10.1038/ng.3940 10.1016/S2352-4642(19)30018-5 10.1158/1541-7786.MCR-11-0134 10.1007/s00109-020-01983-y 10.1002/ijc.32167 10.1038/nature08858 10.1016/j.stemcr.2017.11.020 10.1038/srep13951 10.1186/s13100-016-0065-9 10.1128/MCB.01331-10 10.1080/2159256X.2016.1175537 10.1101/gad.241661.114 10.1074/jbc.M114.631945 10.1038/s41467-020-15155-6 10.1002/gcc.20936 10.1371/journal.pone.0208936 10.1038/s41416-020-01102-1 10.1101/gad.973302 10.1136/jmg.2006.041723 10.1126/science.1216154 10.1038/nrurol.2017.163 10.1074/jbc.R111.252569 10.1681/ASN.2017080887 10.1038/srep39049 10.1186/s12929-017-0374-4 10.1016/j.ygeno.2016.07.003 10.1002/cncr.32855 10.1002/ijc.33147 10.1002/cncr.32958 10.1038/nature14308 10.1242/dev.087585 10.1016/j.canlet.2019.05.013 10.1593/neo.12714 10.1002/ijc.32561 10.1101/gad.317792.118 10.1038/sj.emboj.7601381 10.1242/dev.153163 |
ContentType | Journal Article |
Copyright | 2021 The Authors. published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. 2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2021 The Authors. published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. – notice: 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. – notice: 2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7T5 7TK 7TM 7TO 8FD FR3 H94 K9. P64 RC3 7X8 5PM |
DOI | 10.1002/path.5639 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef Genetics Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | TRIM28 variants and Wilms' tumour predisposition |
EISSN | 1096-9896 |
EndPage | 504 |
ExternalDocumentID | PMC8252630 33565090 10_1002_path_5639 PATH5639 |
Genre | reviewArticle Research Support, Non-U.S. Gov't Journal Article Review |
GrantInformation_xml | – fundername: Stichting Kinderen Kankervrij (KiKa) funderid: 278 – fundername: ; grantid: 278 |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 123 1KJ 1L6 1OB 1OC 1ZS 24P 29L 31~ 33P 3O- 3SF 3UE 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA GSXLS H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M68 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OHT OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI UB1 V2E VH1 W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 XPP XV2 YQI YQJ ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM VXZ 7QP 7QR 7T5 7TK 7TM 7TO 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 H94 K9. P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c4439-c994de1c16ff6843b1f05ad51aff0a351d750d4e15f1924871d95956ec37844e3 |
IEDL.DBID | DR2 |
ISSN | 0022-3417 1096-9896 |
IngestDate | Thu Aug 21 18:43:06 EDT 2025 Fri Jul 11 07:59:18 EDT 2025 Fri Jul 25 12:21:53 EDT 2025 Wed Feb 19 02:27:34 EST 2025 Thu Apr 24 22:55:23 EDT 2025 Tue Jul 01 04:21:20 EDT 2025 Wed Jan 22 16:30:36 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | nephroblastoma KAP1 TRIM28 Wilms' tumour cancer predisposition embryonic kidney development TIF1beta |
Language | English |
License | Attribution-NonCommercial-NoDerivs 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4439-c994de1c16ff6843b1f05ad51aff0a351d750d4e15f1924871d95956ec37844e3 |
Notes | No conflicts of interest were declared. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-3156-5229 0000-0003-4928-3809 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpath.5639 |
PMID | 33565090 |
PQID | 2537525371 |
PQPubID | 1006392 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8252630 proquest_miscellaneous_2488170050 proquest_journals_2537525371 pubmed_primary_33565090 crossref_primary_10_1002_path_5639 crossref_citationtrail_10_1002_path_5639 wiley_primary_10_1002_path_5639_PATH5639 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2021 |
PublicationDateYYYYMMDD | 2021-07-01 |
PublicationDate_xml | – month: 07 year: 2021 text: July 2021 |
PublicationDecade | 2020 |
PublicationPlace | Chichester, UK |
PublicationPlace_xml | – name: Chichester, UK – name: England – name: Bognor Regis |
PublicationTitle | The Journal of pathology |
PublicationTitleAlternate | J Pathol |
PublicationYear | 2021 |
Publisher | John Wiley & Sons, Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Ltd – name: Wiley Subscription Services, Inc |
References | 2002; 16 2010; 55 2021; 124 2016; 108 2017; 49 2013; 23 2019; 15 2015; 33 2010; 464 2020; 126 2010; 463 2019; 366 2014; 24 2020; 14 2014; 29 2020; 11 2014; 28 2012; 14 2012; 10 2014; 21 2012; 51 2020; 6 2004; 129C 2015; 290 2013; 518 2000; 127 2006; 25 2017; 161 2013; 110 2007; 3 2012; 335 2018; 32 2007; 67 2011; 286 2002; 38 2018; 29 2006; 91 2019; 3 2015; 5 2015; 522 2017; 24 2011; 31 2013; 140 2020; 146 2020; 147 2015; 7 2019; 145 2016; 6 2016; 7 2015; 27 2015; 29 2021; 99 2017; 14 2006; 43 2017; 17 2019; 457 2012; 48 2017; 144 2018; 10 2018; 14 2018; 13 1998; 79 e_1_2_8_28_1 e_1_2_8_47_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_3_1 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_66_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_64_1 e_1_2_8_62_1 e_1_2_8_41_1 e_1_2_8_60_1 e_1_2_8_17_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_59_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_57_1 e_1_2_8_32_1 e_1_2_8_55_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_53_1 e_1_2_8_51_1 e_1_2_8_30_1 e_1_2_8_29_1 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_27_1 e_1_2_8_48_1 e_1_2_8_2_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_23_1 e_1_2_8_44_1 e_1_2_8_65_1 Watanabe M (e_1_2_8_24_1) 2017; 161 e_1_2_8_63_1 e_1_2_8_40_1 e_1_2_8_61_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_58_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_56_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_54_1 e_1_2_8_52_1 e_1_2_8_50_1 |
References_xml | – volume: 14 start-page: 743 year: 2017 end-page: 752 article-title: Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol publication-title: Nat Rev Urol – volume: 124 start-page: 437 year: 2021 end-page: 446 article-title: Clinically and biologically relevant subgroups of Wilms tumour defined by genomic and epigenomic analyses publication-title: Br J Cancer – volume: 99 start-page: 477 year: 2021 end-page: 487 article-title: 3D kidney organoids for bench‐to‐bedside translation publication-title: J Mol Med (Berl) – volume: 23 start-page: 452 year: 2013 end-page: 461 article-title: TRIM28 repression of retrotransposon‐based enhancers is necessary to preserve transcriptional dynamics in embryonic stem cells publication-title: Genome Res – volume: 55 start-page: 233 year: 2010 end-page: 238 article-title: Stromal and epithelial predominant Wilms tumours have an excellent outcome: the SIOP 93 01 experience publication-title: Pediatr Blood Cancer – volume: 161 start-page: 135 year: 2017 end-page: 144 article-title: TRIM proteins and diseases publication-title: J Biochem – volume: 14 start-page: 818 year: 2020 end-page: 827 article-title: Infertility‐causing haploinsufficiency reveals TRIM28/KAP1 requirement in spermatogonia publication-title: Stem Cell Reports – volume: 91 start-page: 995 year: 2006 end-page: 999 article-title: Surveillance for Wilms tumour in at‐risk children: pragmatic recommendations for best practice publication-title: Arch Dis Child – volume: 3 year: 2007 article-title: Genome‐wide analysis of KAP1 binding suggests autoregulation of KRAB‐ZNFs publication-title: PLoS Genet – volume: 11 start-page: 1310 year: 2020 article-title: An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity publication-title: Nat Commun – volume: 366 start-page: 1247 year: 2019 end-page: 1251 article-title: Embryonal precursors of Wilms tumor publication-title: Science – volume: 145 start-page: 941 year: 2019 end-page: 951 article-title: TRIM28 haploinsufficiency predisposes to Wilms tumor publication-title: Int J Cancer – volume: 7 start-page: 9 year: 2016 article-title: Roles for retrotransposon insertions in human disease publication-title: Mob DNA – volume: 335 start-page: 1499 year: 2012 end-page: 1502 article-title: Trim28 is required for epigenetic stability during mouse oocyte to embryo transition publication-title: Science – volume: 5 start-page: 13951 year: 2015 article-title: Proteomic analysis of embryonic kidney development: heterochromatin proteins as epigenetic regulators of nephrogenesis publication-title: Sci Rep – volume: 522 start-page: 221 year: 2015 end-page: 225 article-title: Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells publication-title: Nature – volume: 127 start-page: 2955 year: 2000 end-page: 2963 article-title: Mice lacking the transcriptional corepressor TIF1beta are defective in early postimplantation development publication-title: Development – volume: 29 start-page: 467 year: 2015 end-page: 482 article-title: The yin and yang of kidney development and Wilms' tumors publication-title: Genes Dev – volume: 14 year: 2018 article-title: Germline mutations and somatic inactivation of in Wilms tumour publication-title: PLoS Genet – volume: 49 start-page: 1487 year: 2017 end-page: 1494 article-title: A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor publication-title: Nat Genet – volume: 13 year: 2018 article-title: A unique subset of low‐risk Wilms tumors is characterized by loss of function of ( ), a gene critical in early renal development: a Children's Oncology Group study publication-title: PLoS One – volume: 110 start-page: 6841 year: 2013 end-page: 6846 article-title: Acetylated hsp70 and KAP1‐mediated Vps34 SUMOylation is required for autophagosome creation in autophagy publication-title: Proc Natl Acad Sci U S A – volume: 6 start-page: 39049 year: 2016 article-title: Interactomic analysis of REST/NRSF and implications of its functional links with the transcription suppressor TRIM28 during neuronal differentiation publication-title: Sci Rep – volume: 17 start-page: 415 year: 2017 end-page: 424 article-title: Transposable elements in cancer publication-title: Nat Rev Cancer – volume: 518 start-page: 231 year: 2013 end-page: 241 article-title: Retroelements in human disease publication-title: Gene – volume: 457 start-page: 119 year: 2019 end-page: 128 article-title: Origins of DNA methylation defects in Wilms tumors publication-title: Cancer Lett – volume: 3 start-page: 322 year: 2019 end-page: 331 article-title: Identification of new Wilms tumour predisposition genes: an exome sequencing study publication-title: Lancet Child Adolesc Health – volume: 28 start-page: 1397 year: 2014 end-page: 1409 article-title: Evolutionally dynamic L1 regulation in embryonic stem cells publication-title: Genes Dev – volume: 43 start-page: 705 year: 2006 end-page: 715 article-title: Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour publication-title: J Med Genet – volume: 79 start-page: 268 year: 1998 end-page: 273 article-title: Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations publication-title: Am J Med Genet – volume: 27 start-page: 298 year: 2015 end-page: 311 article-title: Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high‐risk blastemal type Wilms tumors publication-title: Cancer Cell – volume: 38 start-page: 79 year: 2002 end-page: 82 article-title: Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood publication-title: Med Pediatr Oncol – volume: 7 start-page: 11 year: 2015 article-title: Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour publication-title: Genome Med – volume: 15 start-page: 240 year: 2019 end-page: 251 article-title: The genetic changes of Wilms tumour publication-title: Nat Rev Nephrol – volume: 147 start-page: 3313 year: 2020 end-page: 3327 article-title: Incidence of childhood renal tumours: an international population‐based study publication-title: Int J Cancer – volume: 126 start-page: 2866 year: 2020 end-page: 2871 article-title: Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: a report from Children's Oncology Group study AREN03B2 publication-title: Cancer – volume: 48 start-page: 3249 year: 2012 end-page: 3256 article-title: Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients publication-title: Eur J Cancer – volume: 290 start-page: 14381 year: 2015 end-page: 14390 article-title: The WTX tumor suppressor interacts with the transcriptional corepressor TRIM28 publication-title: J Biol Chem – volume: 108 start-page: 64 year: 2016 end-page: 77 article-title: RNA polymerase II promoter‐proximal pausing in mammalian long non‐coding genes publication-title: Genomics – volume: 146 start-page: 1010 year: 2020 end-page: 1017 article-title: An eHealth decision‐support tool to prioritize referral practices for genetic evaluation of patients with Wilms tumor publication-title: Int J Cancer – volume: 29 start-page: 681 year: 2014 end-page: 686 article-title: BMP signaling and its modifiers in kidney development publication-title: Pediatr Nephrol – volume: 463 start-page: 237 year: 2010 end-page: 240 article-title: KAP1 controls endogenous retroviruses in embryonic stem cells publication-title: Nature – volume: 6 year: 2020 article-title: congenital predisposition to Wilms' tumor: novel mutations and presentation in a sibling pair publication-title: Cold Spring Harb Mol Case Stud – volume: 67 start-page: 9954 year: 2007 end-page: 9962 article-title: MAGE‐A, mMage‐b, and MAGE‐C proteins form complexes with KAP1 and suppress p53‐dependent apoptosis in MAGE‐positive cell lines publication-title: Cancer Res – volume: 126 start-page: 3516 year: 2020 end-page: 3525 article-title: Results of treatment for patients with multicentric or bilaterally predisposed unilateral Wilms tumor (AREN0534): a report from the Children's Oncology Group publication-title: Cancer – volume: 24 start-page: 63 year: 2017 article-title: The complexity of TRIM28 contribution to cancer publication-title: J Biomed Sci – volume: 33 start-page: 2999 year: 2015 end-page: 3007 article-title: Advances in Wilms tumor treatment and biology: progress through international collaboration publication-title: J Clin Oncol Off J Am Soc Clin Oncol – volume: 129C start-page: 29 year: 2004 end-page: 34 article-title: Familial Wilms tumor publication-title: Am J Med Genet C Semin Med Genet – volume: 14 start-page: 742 year: 2012 end-page: 756 article-title: Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study publication-title: Neoplasia – volume: 286 start-page: 26267 year: 2011 end-page: 26276 article-title: KAP1 protein: an enigmatic master regulator of the genome publication-title: J Biol Chem – volume: 29 start-page: 785 year: 2018 end-page: 805 article-title: Conserved and divergent features of human and mouse kidney organogenesis publication-title: J Am Soc Nephrol – volume: 32 start-page: 993 year: 2018 end-page: 995 article-title: Overgrowth syndromes and pediatric cancers: how many roads lead to IGF2? publication-title: Genes Dev – volume: 10 start-page: 401 year: 2012 end-page: 414 article-title: The ATM substrate KAP1 controls DNA repair in heterochromatin: regulation by HP1 proteins and serine 473/824 phosphorylation publication-title: Mol Cancer Res – volume: 24 start-page: 1260 year: 2014 end-page: 1270 article-title: Interplay of TRIM28 and DNA methylation in controlling human endogenous retroelements publication-title: Genome Res – volume: 10 start-page: 395 year: 2012 end-page: 406 article-title: Studies of endogenous retroviruses reveal a continuing evolutionary saga publication-title: Nat Rev Microbiol – volume: 6 year: 2016 article-title: Transposable elements and miRNA: regulation of genomic stability and plasticity publication-title: Mob Genet Elem – volume: 10 start-page: 243 year: 2018 end-page: 256 article-title: TRIM28‐regulated transposon repression is required for human germline competency and not primed or naive human pluripotency publication-title: Stem Cell Reports – volume: 51 start-page: 92 year: 2012 end-page: 104 article-title: Characterization of primary Wilms tumor cultures as an model publication-title: Genes Chromosomes Cancer – volume: 21 start-page: 876 year: 2014 end-page: 883 article-title: TRIM28 regulates RNA polymerase II promoter‐proximal pausing and pause release publication-title: Nat Struct Mol Biol – volume: 464 start-page: 927 year: 2010 end-page: 931 article-title: Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET publication-title: Nature – volume: 144 start-page: 2862 year: 2017 end-page: 2872 article-title: Wilms' tumour 1 (WT1) in development, homeostasis and disease publication-title: Development – volume: 140 start-page: 519 year: 2013 end-page: 529 article-title: DNA methylation of endogenous retroviruses is shaped by KRAB‐ZFPs/KAP1 and ESET publication-title: Development – volume: 31 start-page: 1833 year: 2011 end-page: 1847 article-title: Functional analysis of KAP1 genomic recruitment publication-title: Mol Cell Biol – volume: 16 start-page: 919 year: 2002 end-page: 932 article-title: SETDB1: a novel KAP‐1‐associated histone H3, lysine 9‐specific methyltransferase that contributes to HP1‐mediated silencing of euchromatic genes by KRAB zinc‐finger proteins publication-title: Genes Dev – volume: 25 start-page: 5214 year: 2006 end-page: 5228 article-title: Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney publication-title: EMBO J – ident: e_1_2_8_10_1 doi: 10.1002/ajmg.c.30025 – ident: e_1_2_8_12_1 doi: 10.1016/j.ejca.2012.06.008 – ident: e_1_2_8_15_1 doi: 10.1371/journal.pgen.1007399 – ident: e_1_2_8_3_1 doi: 10.1186/s13073-015-0136-4 – ident: e_1_2_8_18_1 doi: 10.1200/JCO.2015.62.1888 – ident: e_1_2_8_2_1 doi: 10.1101/gad.256396.114 – ident: e_1_2_8_42_1 doi: 10.1002/(SICI)1096-8628(19981002)79:4<268::AID-AJMG7>3.0.CO;2-I – ident: e_1_2_8_30_1 doi: 10.1101/gr.172833.114 – ident: e_1_2_8_60_1 doi: 10.1002/pbc.22496 – ident: e_1_2_8_39_1 doi: 10.1158/0008-5472.CAN-07-1478 – ident: e_1_2_8_46_1 doi: 10.1007/s00467-013-2671-9 – ident: e_1_2_8_53_1 doi: 10.1016/j.gene.2013.01.008 – ident: e_1_2_8_6_1 doi: 10.1038/s41581-019-0112-0 – ident: e_1_2_8_21_1 doi: 10.1002/mpo.1276 – ident: e_1_2_8_40_1 doi: 10.1073/pnas.1217692110 – ident: e_1_2_8_35_1 doi: 10.1038/nature08674 – ident: e_1_2_8_54_1 doi: 10.1101/gr.147678.112 – ident: e_1_2_8_55_1 doi: 10.1016/j.stemcr.2020.03.013 – ident: e_1_2_8_5_1 doi: 10.1126/science.aax1323 – ident: e_1_2_8_37_1 doi: 10.1242/dev.127.13.2955 – ident: e_1_2_8_49_1 doi: 10.1038/nrmicro2783 – ident: e_1_2_8_8_1 doi: 10.1016/j.ccell.2015.01.002 – ident: e_1_2_8_17_1 doi: 10.1101/mcs.a004796 – ident: e_1_2_8_45_1 doi: 10.1371/journal.pgen.0030089 – ident: e_1_2_8_52_1 doi: 10.1038/nrc.2017.35 – ident: e_1_2_8_59_1 doi: 10.1136/adc.2006.101295 – ident: e_1_2_8_33_1 doi: 10.1038/nsmb.2878 – ident: e_1_2_8_7_1 doi: 10.1038/ng.3940 – ident: e_1_2_8_13_1 doi: 10.1016/S2352-4642(19)30018-5 – ident: e_1_2_8_36_1 doi: 10.1158/1541-7786.MCR-11-0134 – ident: e_1_2_8_63_1 doi: 10.1007/s00109-020-01983-y – ident: e_1_2_8_16_1 doi: 10.1002/ijc.32167 – ident: e_1_2_8_28_1 doi: 10.1038/nature08858 – ident: e_1_2_8_26_1 doi: 10.1016/j.stemcr.2017.11.020 – ident: e_1_2_8_44_1 doi: 10.1038/srep13951 – ident: e_1_2_8_50_1 doi: 10.1186/s13100-016-0065-9 – ident: e_1_2_8_27_1 doi: 10.1128/MCB.01331-10 – ident: e_1_2_8_65_1 doi: 10.1080/2159256X.2016.1175537 – ident: e_1_2_8_48_1 doi: 10.1101/gad.241661.114 – ident: e_1_2_8_57_1 doi: 10.1074/jbc.M114.631945 – ident: e_1_2_8_64_1 doi: 10.1038/s41467-020-15155-6 – ident: e_1_2_8_66_1 doi: 10.1002/gcc.20936 – ident: e_1_2_8_14_1 doi: 10.1371/journal.pone.0208936 – ident: e_1_2_8_23_1 doi: 10.1038/s41416-020-01102-1 – volume: 161 start-page: 135 year: 2017 ident: e_1_2_8_24_1 article-title: TRIM proteins and diseases publication-title: J Biochem – ident: e_1_2_8_31_1 doi: 10.1101/gad.973302 – ident: e_1_2_8_11_1 doi: 10.1136/jmg.2006.041723 – ident: e_1_2_8_38_1 doi: 10.1126/science.1216154 – ident: e_1_2_8_19_1 doi: 10.1038/nrurol.2017.163 – ident: e_1_2_8_25_1 doi: 10.1074/jbc.R111.252569 – ident: e_1_2_8_43_1 doi: 10.1681/ASN.2017080887 – ident: e_1_2_8_56_1 doi: 10.1038/srep39049 – ident: e_1_2_8_32_1 doi: 10.1186/s12929-017-0374-4 – ident: e_1_2_8_34_1 doi: 10.1016/j.ygeno.2016.07.003 – ident: e_1_2_8_61_1 doi: 10.1002/cncr.32855 – ident: e_1_2_8_58_1 doi: 10.1002/ijc.33147 – ident: e_1_2_8_20_1 doi: 10.1002/cncr.32958 – ident: e_1_2_8_51_1 doi: 10.1038/nature14308 – ident: e_1_2_8_29_1 doi: 10.1242/dev.087585 – ident: e_1_2_8_9_1 doi: 10.1016/j.canlet.2019.05.013 – ident: e_1_2_8_22_1 doi: 10.1593/neo.12714 – ident: e_1_2_8_62_1 doi: 10.1002/ijc.32561 – ident: e_1_2_8_4_1 doi: 10.1101/gad.317792.118 – ident: e_1_2_8_47_1 doi: 10.1038/sj.emboj.7601381 – ident: e_1_2_8_41_1 doi: 10.1242/dev.153163 |
SSID | ssj0009955 |
Score | 2.4498909 |
SecondaryResourceType | review_article |
Snippet | TRIM28 was recently identified as a Wilms' tumour (WT) predisposition gene, with germline pathogenic variants identified in around 1% of isolated and 8% of... TRIM28 was recently identified as a Wilms' tumour (WT) predisposition gene, with germline pathogenic variants identified in around 1% of isolated and 8% of... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 494 |
SubjectTerms | cancer predisposition Children Embryogenesis embryonic kidney development Genes, Wilms Tumor Genetic Predisposition to Disease - genetics Genetic screening Heredity Humans Immunohistochemistry Invited Review Invited Reviews KAP1 Kidney Neoplasms - genetics Mutation nephroblastoma TIF1beta Transcription factors TRIM28 Tripartite Motif-Containing Protein 28 - genetics Tumor suppressor genes Tumorigenesis Tumors Wilms Tumor - genetics Wilms' tumour |
Title | TRIM28 variants and Wilms' tumour predisposition |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpath.5639 https://www.ncbi.nlm.nih.gov/pubmed/33565090 https://www.proquest.com/docview/2537525371 https://www.proquest.com/docview/2488170050 https://pubmed.ncbi.nlm.nih.gov/PMC8252630 |
Volume | 254 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LSxxBEIAL40FyiYl5uMbIJATiZdbp1zzISXywBjaIrOAhMPQTJXEUdzeH_PpUzcusRhAvw0BXMzPdXV1V09VfA3wWaIO41SFmThexDEmItTUypjUdnhPULKPdyOPv6ehUfjtTZ0vwtdsL0_Ah-h9upBn1fE0Krs105xYaSif2DhUaWJx_mUiJm79_couOKgqlelK4ZFlHFUr4Tl9z0RbdczDv50n-67_WBuhwFX50r97knfwczmdmaP_coTo-8dtewovWMY12m5H0CpZ8tQYr43bp_TUkk5OjMc-j3xhcU-5MpCsX4ZxyOf0SzeaXWD26vqFNvl0a2Bs4PTyY7I3i9riF2Ep0S2JbFNJ5ZlkaQppLYVhIlHaK6RASLRRz6F046ZkKFLVhpOUKheGVtyLLpfTiLSxXV5Vfhyg36MhINH3eaekd11pbb2yaGZVxw_wAtruGL23LIqcjMX6VDUWZl9QCJbXAAD71otcNgON_Qptd75WtDk5LrkSm6MIG8LEvRu2hJRFd-as5yuD8RYRClQzgXdPZ_VOEUIQXxJJsYRj0AkTmXiypLs5rQjeG3TwVWHO77uWHX7w83p2M6Gbj8aLv4TmnxJo6Z3gTlmc3c_8BPaOZ2YJnXB5v1YrwF-zIC5U |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZSxxBEC7UgOYlGI3JqtFJEPRl4vQ1B-RlCS7rsSKygm9DTx8o6Cjrrr8_VXPpYoS8DANdzQxVXV1fdVd_DbAnMAZxo33IrM5C6SMfalPIkPZ0eEqkZgmdRh6dx8MreXKtrhfgd3sWpuaH6BbcyDOq-ZocnBakD19YQ-nK3l8KI-wifJAxpi7E6ywvXih3M6U6rnDJkpZXKOKHXdf5aPQGYr6tlHyNYKsQNFiFTw12DPq1sT_DgivXYHnU7I6vQzS-PB7xNHjG_JfKWwJd2gDd_v5pP5jOMMefBI8TOofbVmp9gavB0fjPMGxuRAiNROQQmiyT1jHDYu_jVIqC-Uhpq5j2PtJCMYsAwErHlKfECpMhmynMgJwRSSqlExuwVD6U7hsEaYFYQ2J0clZLZ7nW2rjCxEmhEl4w14ODVjO5aejC6daKu7wmOuY5KTEnJfbgZyf6WHNk_Etou1Vv3rjJU86VSBQ9WA9-dM04wGnXQpfuYYYyOMUQiaCKevC1tkb3FSEUMQBiSzJnp06AyLPnW8rbm4pEGzNjHgvseVBZ9P0fzy_64yG9bP6_6C6sDMejs_zs-Px0Cz5yqoOpSny3YWk6mbnvCGSmxU41Xv8CmfHtzA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZSxxBEC7UgPgiSTyyiTFjCOjL6PQ1Bz6JZlmTrCyygm9DTx9E0HFZd_P7rZpLFxXyMgx0NTPU0VXVVf01wA-BPogb7UNmdRZKH_lQm0KGVNPhKYGaJXQaeXgRD67kr2t1vQTH7VmYGh-i23Ajy6jWazLwifVHT6ChdGPvoUIHuwzvJOodqTeXoyfE3UypDipcsqSFFYr4UTd10Rm9iDBfNko-D2ArD9R_D-tN6Bic1LL-AEuu_Airw6Y4vgHR-PJ8yNPgH6a_1N0S6NIGaPV3D_vBbI4p_jSYTOkYbtuotQlX_Z_j00HYXIgQGomBQ2iyTFrHDIu9j1MpCuYjpa1i2vtIC8Us-n8rHVOe8irMhWymMAFyRiSplE5swUp5X7pPEKQFhhoSnZOzWjrLtdbGFSZOCpXwgrkeHLScyU2DFk6XVtzmNc4xz4mJOTGxB9870kkNkfEa0U7L3ryxkoecK5EoerAe7HXDqN9UtNClu58jDa4whCGooh5s19LoviKEIgBAHEkW5NQREHb24kh587fC0MbEmMcCZx5UEn37x_PRyXhAL5__n_QbrI7O-vmf84vfX2CNUxdM1eC7Ayuz6dx9xTBmVuxW6voIYP3tBw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TRIM28+variants+and+Wilms%27+tumour+predisposition&rft.jtitle=The+Journal+of+pathology&rft.au=Hol%2C+Janna+A&rft.au=Diets%2C+Illja+J&rft.au=Krijger%2C+Ronald+R&rft.au=Heuvel%E2%80%90Eibrink%2C+Marry+M&rft.date=2021-07-01&rft.pub=John+Wiley+%26+Sons%2C+Ltd&rft.issn=0022-3417&rft.eissn=1096-9896&rft.volume=254&rft.issue=4&rft.spage=494&rft.epage=504&rft_id=info:doi/10.1002%2Fpath.5639&rft.externalDBID=10.1002%252Fpath.5639&rft.externalDocID=PATH5639 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3417&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3417&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3417&client=summon |